Kopran Limited (BOM:524280)

India flag India · Delayed Price · Currency is INR
156.65
-2.40 (-1.51%)
At close: Apr 29, 2026
-22.14%
Market Cap 7.68B
Revenue (ttm) 6.20B
Net Income (ttm) 165.43M
Shares Out 48.29M
EPS (ttm) 3.42
PE Ratio 46.57
Forward PE n/a
Dividend 3.00 (1.88%)
Ex-Dividend Date Sep 4, 2025
Volume 6,444
Average Volume 30,264
Open 160.50
Previous Close 159.05
Day's Range 155.95 - 160.50
52-Week Range 107.00 - 212.50
Beta 0.43
RSI 61.10
Earnings Date May 15, 2026

About Kopran

Kopran Limited, an integrated pharmaceutical company, engages in the development, manufacture and marketing of active pharmaceutical ingredients and finished dosage forms in India and internationally. The company offers its products in various dosage forms, including tablets, capsules, syrups, dry powder, suspension, and injectables, as well as branded and generic formulations. It also provides drugs in the categories of macrolide, antibacterial, anticonvulsant, anti-hypertensive, anti- helminthics, anti-acne, anti-infective, anti-thrombotic, s... [Read more]

Industry Pharmaceutical Preparations
Founded 1958
Employees 1,024
Stock Exchange Bombay Stock Exchange
Ticker Symbol 524280
Full Company Profile

Financial Performance

In fiscal year 2025, Kopran's revenue was 6.30 billion, an increase of 2.44% compared to the previous year's 6.15 billion. Earnings were 385.52 million, a decrease of -24.34%.

Financial Statements

News

There is no news available yet.